Category
Today's News
More News
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Exercise or snack? How our brain decides

Exercise or snack? How our brain decides

byETH ZurichCredit: CC0 Public DomainShould I go and exercise, or would I rather go to the café and enjoy a delectable strawberry milkshake? Until now, what exactly happens in our brain when we

Exercise or snack? How our brain decides

byETH ZurichCredit: CC0 Public DomainShould I go and exercise, or would I rather go to the café and enjoy a delectable strawberry milkshake? Until now, what exactly happens in our brain when we
US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.
Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.
FDA Approves Lymphir: A New Hope for CTCL Patients

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.
Week’s Top
Podcasts
... Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine... ... Announcement of the 2024 Nobel Prize in Chemistry The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was... ... AlphaFold: The making of a scientific breakthrough The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p...